Margaret A. Tempero

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Inferring liver cancer stage from Medicare claims data: A machine learning approach to broaden outcomes research.

  Journal of Clinical Oncology · 2026-01-10

• Areas of Uncertainty in Pancreatic Cancer Surveillance: A Survey Across the International Pancreatic Cancer Early Detection (PRECEDE) Consortium

  JCO Precision Oncology · 2025-10-01

• 18O Machine learning-based liquid biomarker signatures for predicting success of perioperative and adjuvant chemotherapy in resectable PDAC: Translational data from the NEONAX trial

  ESMO Open · 2025-09-01

• 2245P Evaluation of a cell-free DNA (cfDNA)-based blood test for early detection of pancreatic cancer in high-risk individuals with family history and genetic predisposition

  Annals of Oncology · 2025-09-01

• Five-year outcomes of perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (the NEONAX trial): A randomized phase II trial of the AIO pancreatic cancer group.

  Journal of Clinical Oncology · 2025-05-28

• Machine learning–based liquid biomarker analysis from the NEONAX trial for response prediction to perioperative (PO) and adjuvant (A) gemcitabine/nab-paclitaxel in resectable PDAC (rPDAC).

  Journal of Clinical Oncology · 2025-01-27

• 1505P Exploratory biomarker analysis of the NEONAX trial for response prediction to perioperative (PO) and adjuvant (A) Gem-nabPac chemotherapy (CTX) in resectable PDAC patients (rPDAC Pts)

  Annals of Oncology · 2024-09-01

• Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix

  UNC Libraries · 2024-07-27

• ASO Visual Abstract: Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer

  Annals of Surgical Oncology · 2024-07-27